On January 11th, investors reckoning with the tumultuous stock market may find solace in the following trio of momentum-driven stocks:
ADMA Biologics, Inc. ADMA: This bio-pharmaceutical juggernaut, adorned with a Zacks Rank #1, has witnessed a striking 33.3% surge in the Zacks Consensus Estimate for its earnings over the past 60 days.
Momentum Masters: ADMA Biologics Inc’s Ongoing Triumph
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
ADMA’s shares have surged a remarkable 55.5% over the last three months, leaving the S&P 500’s 8.8% growth eating dust. The company brandishes a Momentum Score of A, a testament to its unwavering ascendancy.
Rising Above: The Rally of Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. ARQT has secured a coveted Zacks Rank #1, witnessing a robust 10.4% surge in the Zacks Consensus Estimate for its current year earnings in the last 60 days.
Arcutis Biotherapeutics, Inc. price-consensus-chart | Arcutis Biotherapeutics, Inc. Quote
Arcutis’ shares have impressively soared 101% over the last month, dwarfing the S&P 500’s 2.5% advance. The company proudly boasts a Momentum Score of A.
The Phenomenal Leap of Phreesia, Inc.
Phreesia, Inc. PHR, a stalwart in SaaS-based software for the healthcare industry, has clinched a Zacks Rank #1. The Zacks Consensus Estimate for its current year earnings has surged an impressive 11.1% over the past 60 days.
Phreesia, Inc. price-consensus-chart | Phreesia, Inc. Quote
Phreesia’s shares have ascended an impressive 41% over the last three months, outperforming the S&P 500’s 8.8% growth. The company’s Momentum Score stands at a commendable B.
For a comprehensive list of top ranked stocks, click here.
To delve deeper into the Momentum Score and its calculation, visit this link.
Zacks Reveals ChatGPT “Sleeper” Stock
One obscure company is on the cusp of a ground-breaking era in the Artificial Intelligence domain. By 2030, the AI sector is slated to unleash an economic force akin to the internet and iPhone, estimated at $15.7 trillion.
To aid investors, Zacks is offering a bonus report that illuminates this explosive growth stock, along with 4 other essential buys, and more.
Download Free ChatGPT Stock Report Right Now >>
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Phreesia, Inc. (PHR) : Free Stock Analysis Report
Arcutis Biotherapeutics, Inc. (ARQT) : Free Stock Analysis Report
The author’s opinions expressed herein do not necessarily reflect those of Nasdaq, Inc.
